Polylite Taiwan Co., Ltd. (TPEX: 1813)
Health Care · Health Care Equipment & Supplies · TW
NT$11.50
-0.43% today · -21.5% 1Y
Polylite Taiwan Co., Ltd. (TPEX: 1813) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $16.84M and employs 149 people.
Over the last twelve months the share price has lost 21.5%, trading between 11.20 and 14.65.
Tweenvest scores Polylite Taiwan Co., Ltd. across four factors: quality 60/100, value 50/100, growth 0/100. Its strongest factor is quality.
1813 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.84M
- Revenue (TTM)
- $9.04M
- P/E
- 52.26
- EPS
- 0.22
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- NT$14.65
- 52-week low
- NT$11.20
- Avg volume (3M)
- —
- Shares outstanding
- 46.64M
- Employees
- 149
- Next earnings
- —
About Polylite Taiwan Co., Ltd.
Polylite Taiwan Co., Ltd. is an international enterprise engaged in the fabrication, refinement, worldwide trade, and retail of a diverse selection of optical lenses, precision optical devices, and medical instruments. A key part of its product line features the GIA series of polycarbonate lenses, offering varieties like FSV, SFSV, progressive, pediatric (KID), and polarized models. This firm, which was established in 1982, conducts its primary operations from Taoyuan, Taiwan.
- ISIN
- TW0001813004
- Founded
- 1982
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $197.44B | $114.10 | -1.75% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $130.86B | $370.42 | -0.38% |
| Stryker CorporationNYSE: SYK | $126.45B | $329.67 | -0.28% |
| Medtronic plcNYSE: MDT | $117.78B | $92.02 | +0.97% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.25B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $69.81B | $48.17 | -3.39% |
| HOYA CorporationTSE: 7741 | $52.40B | ¥24,965.00 | -0.12% |
| Edwards Lifesciences CorporationNYSE: EW | $52.33B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.